Brainstorm Cell Debt To Equity vs. Cash Per Share

BCLI Stock  USD 1.61  0.03  1.90%   
Taking into consideration Brainstorm Cell's profitability measurements, Brainstorm Cell Therapeutics is performing exceptionally good at this time. It has a great odds to showcase excellent profitability results in January. Profitability indicators assess Brainstorm Cell's ability to earn profits and add value for shareholders.
 
Debt To Equity  
First Reported
2010-12-31
Previous Quarter
(0.16)
Current Value
(0.15)
Quarterly Volatility
0.17499185
 
Credit Downgrade
 
Yuan Drop
 
Covid
The Brainstorm Cell's current Operating Cash Flow Sales Ratio is estimated to increase to 29.04, while Price To Sales Ratio is forecasted to increase to (4.2 K). As of now, Brainstorm Cell's Total Other Income Expense Net is increasing as compared to previous years. The Brainstorm Cell's current Interest Income is estimated to increase to about 658.1 K, while Operating Income is forecasted to increase to (20.4 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.210.16
Significantly Up
Very volatile
For Brainstorm Cell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Brainstorm Cell to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Brainstorm Cell Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Brainstorm Cell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Brainstorm Cell Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.45)
Return On Assets
(1.78)
Return On Equity
(11.22)
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Brainstorm Cell Ther Cash Per Share vs. Debt To Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Brainstorm Cell's current stock value. Our valuation model uses many indicators to compare Brainstorm Cell value to that of its competitors to determine the firm's financial worth.
Brainstorm Cell Therapeutics is rated third in debt to equity category among its peers. It is rated below average in cash per share category among its peers fabricating about  0.56  of Cash Per Share per Debt To Equity. The ratio of Debt To Equity to Cash Per Share for Brainstorm Cell Therapeutics is roughly  1.78 . As of now, Brainstorm Cell's Debt To Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brainstorm Cell's earnings, one of the primary drivers of an investment's value.

Brainstorm Cash Per Share vs. Debt To Equity

Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Brainstorm Cell

D/E

 = 

Total Debt

Total Equity

 = 
0.60 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Brainstorm Cell

Cash Per Share

 = 

Total Cash

Average Shares

 = 
0.34 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

Brainstorm Cash Per Share Comparison

Brainstorm Cell is currently under evaluation in cash per share category among its peers.

Brainstorm Cell Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Brainstorm Cell, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Brainstorm Cell will eventually generate negative long term returns. The profitability progress is the general direction of Brainstorm Cell's change in net profit over the period of time. It can combine multiple indicators of Brainstorm Cell, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-21.4 M-20.4 M
Income Before Tax-17.2 M-16.3 M
Total Other Income Expense Net4.2 M4.5 M
Net Loss-17.2 M-16.3 M
Income Tax Expense-490.5 K-466 K
Net Loss-16.6 M-17.5 M
Non Operating Income Net Other-118.8 K-124.7 K
Net Loss-21.8 M-20.8 M
Interest Income626.8 K658.1 K
Net Interest Income-12 K-11.4 K
Change To Netincome1.9 M1.4 M
Net Loss(0.40)(0.42)
Income Quality 1.19  1.25 
Net Income Per E B T 0.88  0.78 

Brainstorm Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Brainstorm Cell. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Brainstorm Cell position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Brainstorm Cell's important profitability drivers and their relationship over time.

Use Brainstorm Cell in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brainstorm Cell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will appreciate offsetting losses from the drop in the long position's value.

Brainstorm Cell Pair Trading

Brainstorm Cell Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Brainstorm Cell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brainstorm Cell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brainstorm Cell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brainstorm Cell Therapeutics to buy it.
The correlation of Brainstorm Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brainstorm Cell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brainstorm Cell Ther moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brainstorm Cell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Brainstorm Cell position

In addition to having Brainstorm Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Losers Thematic Idea Now

Latest Losers
Latest Losers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 235 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:
Check out Trending Equities.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
To fully project Brainstorm Cell's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Brainstorm Cell Ther at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Brainstorm Cell's income statement, its balance sheet, and the statement of cash flows.
Potential Brainstorm Cell investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Brainstorm Cell investors may work on each financial statement separately, they are all related. The changes in Brainstorm Cell's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Brainstorm Cell's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.